Roche to Acquire Biotech Firm

Roche Holding agreed to buy biotech company InterMune for $8.3 billion in cash, the biggest acquisition in years for the Swiss pharmaceutical giant after a string of smaller purchases.



from WSJ.com: US Business http://ift.tt/YR4KM1

via IFTTT